This blog is related to the various litigations related to patents w.r.t pharma industry.
Monday, July 27, 2009
FDA Finalizes Authorized Generics Reporting Rule; Electronic Submissions Will be Permitted and Eventually Required
On July 28, 2009, FDA will publish a final rule amending the Agency’s regulations requiring that NDA holders submit in annual reports certain information to the Agency concerning authorized generics.
No comments:
Post a Comment